VRDN
#1923
Viridian Therapeutics, Inc. - Common Stock
18.3 0 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.93%
Variazione Mensile
-14.76%
Variazione di 6 mesi
+22.24%
Variazione Annuale
-18.49%
Chiusura Precedente
18.6 6
Open
19.0 0
Minimo
18.2 1
Massimo
19.1 9
Financials
2023
Current report, 29 Oct 2023
Viridian Therapeutics, Inc. current report, 29 October 2023
8-K
Quarterly report, Q3 FY2023
Viridian Therapeutics, Inc. quarterly report, Q3 FY2023
10-Q
Current report, 21 Sep 2023
Viridian Therapeutics, Inc. current report, 21 September 2023
8-K
Current report, 08 Sep 2023
Viridian Therapeutics, Inc. current report, 08 September 2023
8-K
Current report, 17 Jul 2023
Viridian Therapeutics, Inc. current report, 17 July 2023
8-K
Current report, 10 Jul 2023
Viridian Therapeutics, Inc. current report, 10 July 2023
8-K
Quarterly report, Q2 FY2023
Viridian Therapeutics, Inc. quarterly report, Q2 FY2023
10-Q
Current report, 14 Jun 2023
Viridian Therapeutics, Inc. current report, 14 June 2023
8-K
Current report, 09 May 2023
Viridian Therapeutics, Inc. current report, 09 May 2023
8-K
Current report, 11 Apr 2023
Viridian Therapeutics, Inc. current report, 11 April 2023
8-K